EUCTR2020-002708-38-SE进行中（未招募）1 期
Optimized pharmacological treatment for broken heart (takotsubo) syndrome
Department of Medical Science Gothenburg University0 个研究点目标入组 1,000 人开始时间: 2020年6月5日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •A clinical diagnosis of Takotsubo syndrome
- •Age above 18 years
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 700
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 300
排除标准
- •Any contra indication for treatment with adenosine or dipyridamole
- •Ongoing treatment with dipyridamole
- •Life expectancy of less than one month
研究者
相似试验
招募中
1 期
Optimized pharmacologic treatment for broken heart (takotsubo) syndromeTakotsubo syndromeCTIS2022-501874-21-00Vastra Gotalandsregionen1,600
招募中
不适用
The establishment of the effective treatment for hyperuricemia in hypertensive patient with hyperuricemiahyperuricemiaJPRN-UMIN000010222ational Cerebral and Cardiovascular Center20
已完成
不适用
Examining a unique medication for alcoholic smokersAlcohol dependenceISRCTN62137064ABMRF/The Foundation for Alcohol Research (USA)30
已完成
4 期
Combination drug therapy for fibromyalgia paiMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN20173707Queen's University (Canada)69
进行中（未招募）
不适用
ew pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands.EUCTR2009-010584-16-NLZonMw